HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment.

AuthorsPetr Szturz, Zdeněk Adam, Vladimír Vašků, Josef Feit, Marta Krejčí, Luděk Pour, Roman Hájek, Jiří Mayer
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 54 Issue 6 Pg. 1324-6 (Jun 2013) ISSN: 1029-2403 [Electronic] United States
PMID23061634 (Publication Type: Case Reports, Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Boronic Acids
  • Pyrazines
  • Bortezomib
Topics
  • Antineoplastic Agents (therapeutic use)
  • Boronic Acids (therapeutic use)
  • Bortezomib
  • Humans
  • Male
  • Middle Aged
  • Multiple Myeloma (complications, drug therapy)
  • Phenotype
  • Pyrazines (therapeutic use)
  • Remission Induction
  • Scleredema Adultorum (diagnosis, etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: